![[LSF] Life-Sciences-France.com - The French Life Sciences Web Portal](/images/basics/lsf-life-sciences-france-portal-logo.svg){kind=logo}
Advertisement
Persons > All
France
Monaco
Central France
Eastern France
Northern France
Paris (region)
Southern France
Western France
Find below all kinds of persons from France & Monaco.Total search results: 2517 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Abastado, Jean-Pierre (Servier 201507 Director Oncology Innovation Therapeutic Pole) | Research & Development Manager | Servier (Group) | Île-de-France (region) |
| Abate, Emmanuel (Danaher 202210 President Genomic Medicine at Cytiva) | President/Director/Head Business Group/Unit/Division | Danaher (Group) | South East England (region) |
| Abdellaoui, Hautman (RED Horticulture 202311 CFO) | Chief Financial Officer (CFO) | RED Horticulture (Rouge Engineered Designs) (Group) | Auvergne-Rhône-Alpes (region) |
| Aberg, Louise (McDermott Will & Emery 201701 Associate in Life Sciences Group in Paris) | Attorney / Lawyer | McDermott Will & Emery (MWE) (Group) | Île-de-France (region) |
| Abitbol, Jacky (Cathay Capital 202412 Partner at Cathay Innovation) | Partner (venture partner) | Cathay Capital (Group) | Île-de-France (region) |
| Abou-Jaoudé, Naïm (New York Life 202412 CEO of New York Life Investment Management) | Chief Executive Officer (CEO) | New York Life (Group) | New Jersey (federal state) |
| Abribat, Thierry (Alizé Pharma 2007– President + Founder) | Chief Executive Officer (CEO) | Alizé Pharma (Group) | Auvergne-Rhône-Alpes (region) |
| Achard, Bruno (JEOL 201501 CEO of JEOL (Europe) SAS) | Chief Executive Officer (CEO) | JEOL (Group) | Île-de-France (region) |
| Ackermann, Bastian (Miltenyi Biotec 201807 Global Product Manager MACSQuant Tyto) | Product Manager (personnel) | Miltenyi Biotec (Group) | Nordrhein-Westfalen (federal state) |
| Adams, Thorsten (Sartorius 201705 Director of Product Management for Fermentation Technologies at SSB) | Product Manager (personnel) | Sartorius (Group) | Niedersachsen (federal state) |
| Adelus, Benoît (Sebia 200802– before Eurofins EVP + bioMérieux CEO + Merial) | Chief Executive Officer (CEO) | Sebia (Group) | Île-de-France (region) |
| Afeyan, Noubar (Flagship Ventures 200603 managing partner + CEO) | Chief Executive Officer (CEO) | Flagship Pioneering | Massachusetts (federal state) |
| Affagard, Hervé (MaaT Pharma 201507 CEO) | Chief Executive Officer (CEO) | MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT) | Auvergne-Rhône-Alpes (region) |
| Afonso, Carlos (Univ Rouen 201606) | Laboratory Manager (industry) | University of Rouen (Université de Rouen) | Normandie (Normandy) (region) |
| Afshar, Mohammad (Ariana Pharmaceuticals 2002– CEO + Founder) | Chief Executive Officer (CEO) | Ariana Pharmaceuticals (Group) | Île-de-France (region) |
| Agarwal, Shefali (Valerio Therapeutics 202404 CEO before Onxeo 202201 Board Chair) | Chief Executive Officer (CEO) | Valerio Therapeutics (Group) | Île-de-France (region) |
| Agnus, Jean-Baptiste (JB) (JSR Corp 202404– CBO at KBI Biopharma before AGC Biologics + Ajinomoto Bio-Pharma + Novasep) | Chief Business Officer (CBO) | JSR Corporation (Group) | North Carolina (federal state) |
| Agon, Jean-Paul (L’Oréal 201812 CEO) | Chief Executive Officer (CEO) | L’Oréal (Group) | Île-de-France (region) |
| Agostino-Etchetto, Florence (Lyonbiopole 201306– Managing Director joined 201209 before Hospices Civils de Lyon) | Cluster Manager | Lyonbiopôle | Auvergne-Rhône-Alpes (region) |
| Aguilar, Luc (L’Oréal 201402 Head of Biotechnologies Dept) | President/Director/Head Business Group/Unit/Division | L’Oréal (Group) | Île-de-France (region) |
| Aiach-Pignet, Karen (Genespire 202409– CEO before Lysogene CEO + Founder) | Chief Executive Officer (CEO) | Genespire S.r.l. | Lombardia (Lombardy) |
| Al-Wakeel, Yasir (Kronos Bio 202008– CFO + Head of CorpDev before Neon Therapeutics + Merrimack Pharma + Credit Suisse) | Chief Financial Officer (CFO) | Kronos Bio Inc. (Nasdaq: KRON) | California (federal state) |
| Alba, Florent (NewCap 201502) | Public Relations Manager / Investor Relations Manager | NewCap. – Investor Relations & Financial Communications | Île-de-France (region) |
| Alberici, Gilles (Orega Biotech 201601 CEO before Octalfa 2009 President before OPi SA founder + president) | Chief Executive Officer (CEO) | Orega Biotech (FR) | Auvergne-Rhône-Alpes (region) |
| Albers, Jeffrey W. (Jeff) (Blueprint Medicinces 201201– President of Algeta US + Genzyme + Mintz Levin) | Chief Executive Officer (CEO) | Blueprint Medicines (Group) | Massachusetts (federal state) |
| Albert, Matthew (Institut Pasteur 201501 Director of Immunology Dept) | President/Director/Head of Research Organisation/Unit | Institut Pasteur | Île-de-France (region) |
| Albou, Laurent-Philippe (Bionext 2009– CEO + Co-founder) | Company Founder | Bionext (FR) | Grand Est (Great East) (region) |
| Albou, Serge-Henri (Bionext 2009– CEO + Co-founder) | Chief Executive Officer (CEO) | Bionext (FR) | Grand Est (Great East) (region) |
| Aldag, Jörn (Hookipa Biotech 201606– CEO before Uniqure/AMT + Evotec + MAN GHH) | Chief Executive Officer (CEO) | Hookipa (Group) | Wien (state) |
| Alem, Liza (AZMed 202402 Head of Marketing + Communication) | Sales Manager / Marketing Manager | AZmed SAS | Pays de la Loire (region) |
| Alessandri, Kévin (TreeFrog Therapeutics 202201– Managing Director TreeFrog Tx Inc before CEO + CTO + Co-Founder) | Chief Executive Officer (CEO) | TreeFrog Therapeutics (Group) | Massachusetts (federal state) |
| Alldread, Richard (Lonza 201107 Head Technology Development + Strategic Projects at Lonza Development Services) | Technical Manager | Lonza (Group) | Northwestern Switzerland (region) |
| Allemond, Pierre (Protein Metrics 201510– VP European Sales before Biovia/Dassault Systèmes + Accelrys + Chemspeed) | Sales Manager / Marketing Manager | Siemens (Group) | Région Lémanique (region) |
| Allmond, David (Novacyt 202110 CEO before Amryt Pharma + Amgen + Celgene + Aegerion Pharmaceuticals) | Chief Executive Officer (CEO) | Novacyt (Group) | Île-de-France (region) |
| Allouche, Christian (Gleamer 202306 CEO + Co-Founder) | Chief Executive Officer (CEO) | Gleamer SAS | Île-de-France (region) |
| Allouche, Florence (SparingVision –202010 President + Co-Founder LEFT 10/20) | President/Director/Head Business Group/Unit/Division | SparingVision (Group) | Île-de-France (region) |
| Alsat, Valentin (Flash Therapeutics 202307 Financial Manager) | Chief Financial Officer (CFO) | Flash BioSolutions (Group) | Occitanie (Occitania) (region) |
| Altaba, Stéphane (LXRepair 202101– CEO before Genomic Vision + Nordic Pharma + Sanofi + Riken) | Chief Executive Officer (CEO) | LXRepair SAS | Auvergne-Rhône-Alpes (region) |
| Álvarez, Leonardo (Protera 202006 CEO + Co-Founder) | Chief Executive Officer (CEO) | Protera (Group) | Île-de-France (region) |
| Amann, Rudolf | n. a. | Max Planck Society for the Advancement of Science | Bremen (federal state) |
| Amato, Marcos (Agdia 201508 Managing Director of Agdia-Biofords) | Managing Director | Agdia (Group) | Île-de-France (region) |
| Amidi, Saeed (Plug and Play 201706 CEO + Founder) | Chief Executive Officer (CEO) | Plug and Play (Group) | California (federal state) |
| Amoroso, Michael (Precision BioSciences 202110– CEO before Abeona Tx + Gilead/Kite + Eisai Inc + Celgene + Sanofi) | Chief Executive Officer (CEO) | Precision BioSciences (Group) | North Carolina (federal state) |
| Amsallem, Gilles (Arbiom 201603 CEO before Biométhodes SA CEO) | Chief Executive Officer (CEO) | Arbiom (Group) | Virginia (federal state) |
| Amzal, Billy (Quinten 202209 CEO of Quinten Health) | Chief Executive Officer (CEO) | Quinten (Group) | Île-de-France (region) |
| Anciaux, Jean-Patrice (France (govt) 202001 Investment Director at Bpifrance Digital Venture) | Investment Manager | France (govt) | Île-de-France (region) |
| Anderson, Joe (Sofinnova Partners 2022 Partner before Arix Bioscience + Abingworth) | Investment Manager | Sofinnova (Group) | Île-de-France (region) |
| Ando, Osamu (Shimadzu 201005 General Manager Analytical & Measuring Instruments Div) | General Manager (management) | Shimadzu (Group) | Kinki (region) |
| Andréucci, Philippe (APIX 201302 VP Business Development + Co-founder) | Business Development Manager / Strategy Manager | Analytical Pixels Technology SAS (APIX) | Auvergne-Rhône-Alpes (region) |
| Anglade, Eddy (Tenpoint Therapeutics 202307 CEO) | n. a. | ||
| Angot, Alexis (Ynsect 2011– Co-founder) | Company Founder | Ynsect SAS | Île-de-France (region) |
| Anido, Judit (Nuage Therapeutics 202205–202503 CEO + Co-Founder before Northern Biologics + Mosaic Biomedicals LEFT) | Chief Executive Officer (CEO) | Nuage Therapeutics S.L. | Catalonia |
| Ankri, Sarah (Lysogene 201710 VP Finance before Theraclion 201508 CFO + Board Director of Biotech France) | Chief Financial Officer (CFO) | Lysogene S.A. (Euronext Paris: LYS) | Île-de-France (region) |
| Annable, Mike (Lab21 201202 Director Clinical Lab division) | Laboratory Manager (industry) | Novacyt (Group) | South East England (region) |
| Antonelli, Pierluigi (Fresenius 202303– CEO of Fresenius Kabi formerly CEO of Angelini Pharma) | Chief Executive Officer (CEO) | Fresenius (Group) | Germany (state/region unspecified) |
| Antoni, Christian (Sanofi 201502 VP + Head Immunology + Inflammation Franchise RnD) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Antonijevic, Irina (Sanofi 201208 Director Clinical Research at Sanofi US) | Research & Development Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Antonini, Mathieu (Axa 201109 Managing Director of Axa Private Equity) | n. a. | Ardian (Group) | Île-de-France (region) |
| Arabian, Bruno (Ulysse Communication 201807 before Milestones 201511) | Public Relations Manager / Investor Relations Manager | Ulysse Communication GIE | Île-de-France (region) |
| Aragues, Alain (Cephalon Europe 200512) | n. a. | Teva (Group) | France (region/state unspecified) |
| Arango, Jaime (MedinCell 202005 CFO) | Chief Financial Officer (CFO) | MedinCell (Group) | Occitanie (Occitania) (region) |
| Archambeau, Eric (Astanor Ventures 202209 Managing Partner + Co-Founder) | Company Founder | Astanor Ventures (BE) | Belgium_o |
| Archinard, Philippe (Institu Mérieux 202101– EVP Technological Innovation + Scientific Partnerships before Transgene) | Chief Executive Officer (CEO) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Arie, Jean-Philippe (Luxembourg (govt) 201803– Manager of BioHealth Cluster before Genopole) | Cluster Manager | Luxembourg (govt) | Luxembourg (cl=4) |
| Armstrong, Brian (bioMérieux 202203 SVP Clinical Operations North America) | n. a. | Mérieux (Group) | North Carolina (federal state) |
| Arnot, Christopher (Merck (DE) 202209 Director BusDev + Licensing Gene Editing + Novel Modalities at Sigma-Aldrich) | Business Development Manager / Strategy Manager | Merck (DE) (Group) | Missouri (federal state) |
| Arthaud, Laurent (France (govt) 202103 Director of Biotech + Ecotech Investment at Bpifrance) | Investment Manager | France (govt) | Île-de-France (region) |
| Artusio, Lionel (Z Impact Ventures 202407 General Partner) | General Partner (venture partner) | Z Impact Ventures (d/b/a Zebra Impact Ventures) | Région Lémanique (region) |
| Arwani, Erfane (Biomemory 202211 CEO + Co-Founder) | Chief Executive Officer (CEO) | Biomemory SAS | Île-de-France (region) |
| Aspinall, Mara G. (Roche 201109– President Ventana Medical before On-Q-ity founder + CEO before Genzyme) | President/Director/Head Business Group/Unit/Division | LabCorp (Group) | Massachusetts (federal state) |
| Atieh, Michael G. (OSI Pharmaceuticals –200812 CFO retired 1/09) | Chief Financial Officer (CFO) | Astellas (Group) | New York (federal state) |
| Attard, Romain (Tissium 202107– CFO before a decade at Oddo BHF) | Chief Financial Officer (CFO) | Tissium (Group) | Île-de-France (region) |
| Attuil, Valérie (Mablink Bioscience 202104 COO) | Chief Operating Officer (COO) | Eli Lilly (Group) | Auvergne-Rhône-Alpes (region) |
| Aubry, Xavier (Da Vinci Labs 2021– CEO + Founder) | Chief Executive Officer (CEO) | Da Vinci Labs SAS | France (region/state unspecified) |
| Audebert, Benjamin (Carbios 201601 Investor Relations) | Public Relations Manager / Investor Relations Manager | Carbios (Group) | Auvergne-Rhône-Alpes (region) |
| Audoly, Laurent (Parthenon Therapeutics 201909– CEO + Co-Founder before Kymera Therapeutics + Pierre Fabre + Pieris) | Chief Executive Officer (CEO) | Parthenon Therapeutics (US) | Massachusetts (federal state) |
| Audouard, Emmanuel (France (govt) 201709 Director of PSIM Fund at bpifrance) | Investment Manager | France (govt) | France (region/state unspecified) |
| Augé, Pascale (INSERM 201403– CEO of Inserm Transfert before Institut Pasteur + Neurotech + Entomed + AB Science) | Chief Executive Officer (CEO) | France (govt) | Île-de-France (region) |
| Auguin, Anne-Cécile (EU (govt) 201707 EIB) | Public Relations Manager / Investor Relations Manager | EU (govt) | Luxembourg (cl=4) |
| Aurore, Sergeant (Mérieux 201302– Head of Corporate Communications at bioMérieux joined 4/11) | Public Relations Manager / Investor Relations Manager | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Authié, Dominique (Pierre Fabre 201805 Director of Operations France at Pierre Fabre Pharmaceuticals) | n. a. | Pierre Fabre (Group) | France (region/state unspecified) |
| Autier, Valérie (Metabrain Research 200903– CEO + Co-Founder) | Chief Executive Officer (CEO) | Metabrain Research SAS | Île-de-France (region) |
| Autret, Arnaud (Illumina 202205– Head of European Operations at Illumina Ventures before M Ventures) | Principal (venture capital) | Illumina (Group) | California (federal state) |
| Avenard, Gilles (Acticor Biotech 201612 CEO) | Chief Executive Officer (CEO) | Acticor Biotech (Group) | Île-de-France (region) |
| Axelson, Dodi (Danaher 202210 Head of Communciations at Cytiva) | Public Relations Manager / Investor Relations Manager | Danaher (Group) | South East England (region) |
| Ayache, André (Waters 201211 VP + General Manager European Operations at Waters Division) | General Manager (management) | Waters (Group) | Île-de-France (region) |
| Azogui, Micheline (Euromedex 200609 Product Manager) | Product Manager (personnel) | Euromedex | Grand Est (Great East) (region) |
| Babeau, Emmanuel (Schneider Electric Group 201803 CFO + Deputy CEO before Pernod Ricard) | n. a. | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Babler, Martin (Principia Biopharma 202008 CEO) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | California (federal state) |
| Bachelot-Fontaine, Laetitia (Valneva 201404 Investor Relations + Communications Manager) | Public Relations Manager / Investor Relations Manager | Valneva (Group) | Pays de la Loire (region) |
| Baer, Thomas M. (Arcturus –200412 CEO + founder) | Chief Executive Officer (CEO) | Hologic (Group) | California (federal state) |
| Baeten, Kristoff (Monkeys not Donkeys 202204 CEO + Founder) | Chief Executive Officer (CEO) | QbD Group (Quality by Design) (Group) | Flanders (Flemish region) |
| Baguenault, Michel (Mérieux 201608 Secretary General at bioMérieux) | n. a. | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Bahi, Khaled (Stilla Technologies 201911– CFO before Symetis + Fresenius Medical Care) | Chief Financial Officer (CFO) | Bio-Rad (Group) | Île-de-France (region) |
| Bains, Peter (MiNA Therapeutics 202009– CBO before Sosei Heptares + Biocon/Syngene International + GSK) | Chief Business Officer (CBO) | MiNA Therapeutics Ltd. | Greater London (region) |
| Baker, Matthew (Matt) (NeoPhore 202003– CEO joined 5/19 before Denceptor Therapeutics + Abzena + Antitope + Biovation) | Chief Executive Officer (CEO) | NeoPhore Ltd. | North West England (region) |
| Baker, Tim (Baker & Yorke 201409 Partner) | Public Relations Manager / Investor Relations Manager | Baker & Yorke Inc. | Ohio (federal state) |
| Baldus, Berthold (Cisbio Bioassays 201311 CEO) | Chief Executive Officer (CEO) | PerkinElmer (Group) | France (region/state unspecified) |
| Ballal, Rahul (Mediar Therapeutics 202303 CEO before Imara) | Chief Executive Officer (CEO) | ||
| Balster, Kay G. (High-Tech Gründerfonds 201202 Investment Manager) | Investment Manager | High-Tech Gründerfonds (HTGF) (Group) | Nordrhein-Westfalen (federal state) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
